Study guide

1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment

C-OBE Obstetric Emergencies Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems

1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness

2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing

3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion

3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)

4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features

4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia

5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy

5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management

6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean

6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)

7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States

7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

8 Chapter 8: Acute Intrapartum Delivery Emergencies

8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols

9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma

9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage

10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections

10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections

11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)

12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies

12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration

13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol

14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity

14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies

1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment

Key Takeaways Explain This Topic AI

Maternal Early Warning Trigger (MEWT) protocols establish standardized critical action thresholds: SBP <90 or >160 mmHg, DBP >100 mmHg, HR <50 or >120 bpm, RR <10 or >30 breaths/min, SpO2 <95%, and oliguria <35 mL/hr for >=2 hours.

Due to a 40% to 50% expanded plasma volume and compensatory systemic vasoconstriction, pregnant women can lose 1,000 to 1,500 mL of blood (up to 30% to 35% of total blood volume) before manifesting classic arterial hypotension; Category II/III fetal heart rate decelerations and maternal resting tachycardia often serve as the earliest indicators of occult hemorrhagic shock.

A Shock Index (HR / SBP) >=0.9 in pregnancy indicates significant occult blood loss and impaired tissue perfusion, while a Shock Index >=1.4 indicates life-threatening shock requiring immediate massive transfusion protocol activation.

Viscoelastic point-of-care coagulation testing (TEG / ROTEM) provides real-time functional assessment of clotting kinetics, guiding targeted component therapy: prolonged R-time/CT indicates clotting factor deficiency requiring FFP, reduced alpha-angle/CFT indicates hypofibrinogenemia requiring cryoprecipitate, and reduced MA/MCF indicates platelet deficiency.

Bedside Point-of-Care Ultrasound (POCUS / FAST) rapidly identifies occult intra-abdominal hemorrhage (Morison's pouch, splenorenal recess, pelvis), collapsed inferior vena cava (IVC) indicating hypovolemia, and confirms fetal cardiac activity without delaying maternal resuscitation.

Last updated: August 2026

Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment

Maternal clinical deterioration is frequently preceded by subtle physiological aberrations that go unrecognized until catastrophic collapse occurs. National maternal mortality reviews reveal that failure to recognize abnormal vital signs and delays in escalating care are among the most prevalent preventable contributors to maternal death. Standardized Maternal Early Warning Systems provide an objective, evidence-based safety net to trigger rapid bedside assessment and definitive intervention.

1. NPMS & National MEWT Vital Sign Triggers and Thresholds

The National Partnership for Maternal Safety (NPMS) and the Council on Patient Safety in Women's Health Care developed the Maternal Early Warning Trigger (MEWT) tool. A single severe vital sign abnormality (Red Trigger) or two concurrent moderate abnormalities (Yellow Triggers) mandates an immediate bedside clinical evaluation, physician notification, and diagnostic workup.

Physiological Parameter Normal Pregnancy Range Moderate Trigger (Yellow) Severe Critical Trigger (Red) Clinical Significance & Action Threshold

Systolic Blood Pressure (SBP) 100–130 mmHg 150–159 mmHg or 90–99 mmHg >160 mmHg or <90 mmHg SBP >160 triggers emergency antihypertensive protocol within 30–60 min; SBP <90 indicates decompensated shock or sepsis.

Diastolic Blood Pressure (DBP) 60–80 mmHg 90–99 mmHg >100–110 mmHg DBP >=110 is severe hypertension requiring immediate treatment; DBP >100 confirmed requires urgent preeclampsia workup.

Heart Rate (HR) 70–95 bpm 100–119 bpm or 50–59 bpm >120 bpm or <50 bpm Sustained HR >120 indicates occult hemorrhage, severe sepsis, pulmonary embolism, or thyroid storm. HR <50 suggests complete heart block or severe drug toxicity.

Respiratory Rate (RR) 12–20 breaths/min 21–29 breaths/min >30 breaths/min or <10 breaths/min RR >30 is an early sign of metabolic acidemia (DKA, sepsis, shock) or pulmonary edema; RR <10 indicates opioid/magnesium toxicity.

Oxygen Saturation (SpO2) 97–100% (Room Air) 95–96% <95% on room air (or <92% with supplemental O2) Hypoxemia: pulmonary edema (tocolytic/preeclampsia-related), amniotic fluid embolism (AFE), pulmonary embolism, or aspiration pneumonia.

Urine Output (Oliguria) >=35–50 mL/hr 20–34 mL/hr for 2 consecutive hours <35 mL/hr for >=2 hours (or <20 mL/hr for 1 hour) Acute kidney injury, severe preeclampsia with end-organ injury, or under-resuscitated hypovolemic/septic shock.

Neurological / Mental Status Alert, oriented x 4 Mild agitation, anxiety, new mild headache Confusion, somnolence, stupor, coma, agitation, severe persistent visual scotomata Intracranial hemorrhage, cerebral edema from severe preeclampsia/eclampsia, severe hypoxemia, or sepsis encephalopathy.

Maternal Temperature 36.5–37.5°C 37.6–37.9°C >38.0°C (100.4°F) or <36.0°C (96.8°F) Sepsis, chorioamnionitis, intra-abdominal abscess; hypothermia indicates severe septic shock or coagulopathy.

  • 2. Maternal Physiologic Compensation & The Masking of Shock
  • The Compensatory Mechanism

Normal gestational adaptations create a massive physiological buffer:

Expanded Blood Volume: Circulating plasma volume expands by 1,200 to 1,600 mL, providing an extensive autologous fluid reserve.

Uteroplacental Perfusion: The gravid uterus receives 700 to 900 mL/min of blood flow (12% to 15% of total cardiac output) via low-resistance, non-autoregulated spiral arterioles.

When acute hemorrhage occurs, powerful sympathetic activation releases endogenous catecholamines (epinephrine, norepinephrine), driving intense selective splanchnic and uteroplacental vasoconstriction and systemic tachycardia. Central venous return and arterial blood pressure are maintained at normal levels while blood is actively shunted away from the uterus and kidneys to preserve maternal cerebral and coronary perfusion. +---------------------------------------------------------------------------------------------------+

  • | THE CLINICAL TRAP OF OBSTETRIC SHOCK |
  • | |
  • | • A pregnant patient can lose 1,000 to 1,500 mL (30% to 35%) of total blood volume before |
  • | manifesting a drop in systolic blood pressure! |
  • | • When arterial hypotension (SBP <90 mmHg) finally develops, maternal physiological compensatory|
  • | mechanisms are entirely exhausted, indicating SUDDEN, IMMINENT CARDIOVASCULAR COLLAPSE. |
  • | • THE FETUS IS THE 'CANARY IN THE COAL MINE': Because the uteroplacental bed lacks |
  • | autoregulation, maternal vasoconstriction immediately starves the intervillous space. |
  • | Category II/III fetal heart rate changes (loss of accelerations, minimal variability, late |
  • | decelerations, or prolonged decelerations) are frequently the EARLIEST clinical indicators of |
  • | severe maternal occult hemorrhage! |
  • +---------------------------------------------------------------------------------------------------+
  • The Obstetric Shock Index (SI)

To overcome the masking of shock by arterial blood pressure, the Shock Index (SI) is calculated at the bedside: Shock Index (SI) = Heart Rate (bpm) Systolic Blood Pressure (mmHg) \text{Shock Index (SI)} = \frac{\text{Heart Rate (bpm)}}{\text{Systolic Blood Pressure (mmHg)}} Shock Index (SI) = Systolic Blood Pressure (mmHg) Heart Rate (bpm) ​

Normal Range in Pregnancy: 0.5 to 0.7

SI >= 0.9: Highly sensitive predictor of significant occult hemorrhage, massive blood loss (>1,000 mL), and the need for urgent blood component transfusion. Prompts immediate escalation to Hemorrhage Stage 2.

SI >= 1.4: Indicates profound, life-threatening hemorrhagic shock with high mortality risk; triggers immediate activation of the Massive Transfusion Protocol (MTP) .

3. Systematic Physical Assessment in Obstetric Critical Care

When a MEWT trigger is activated, a comprehensive physical assessment must be executed systematically: +---------------------------------------------------------------------------------------------------+

  • | CRITICAL TRIAGE PHYSICAL ASSESSMENT CHECKLIST |
  • | |
  • | 1. NEUROLOGICAL: Level of consciousness (AVPU / GCS); presence of Clonus (dorsiflexion of foot, |
  • | >=3 beats indicates hyperreflexia/CNS irritability); visual fields; pupillary reactivity. |
  • | 2. CARDIOPULMONARY: Auscultate lung bases for pulmonary crackles (pulmonary edema vs aspiration);|
  • | assess for jugular venous distension (JVD) or third heart sound (S3); respiratory effort. |
  • | 3. ABDOMINAL & FUNDAL EVALUATION: |
  • | • Fundal Height & Position: Boggy, elevated, or shifted fundus indicates concealed uterine |
  • | atony or bladder distension. |
  • | • Uterine Resting Tone: A 'woody-hard', hypertonic, severely tender uterus indicates acute |
  • | concealed PLACENTAL ABRUPTION. |
  • | • Abdominal Tenderness: Rebound, guarding, or rigid abdomen indicates hemoperitoneum from |
  • | uterine rupture or ruptured ectopic pregnancy. |
  • | 4. PELVIC & GENITAL INSPECTION: |
  • | • ALWAYS visualize with sterile speculum BEFORE digital vaginal exam if placental location is |
  • | unknown, to avoid digital disruption of placenta previa/vasa previa. |
  • | • Direct inspection for vaginal wall, fornix, or cervical lacerations and vulvovaginal |
  • | hematomas (which can conceal 1,000+ mL of blood without visible external bleeding). |
  • | 5. PERIPHERAL PERFUSION: Capillary refill time (>3 seconds indicates vasoconstriction/shock); |
  • | distal pulse volume (weak, thready pulses); bilateral lower extremity edema / DVT assessment.|
  • +---------------------------------------------------------------------------------------------------+
  • 4. Point-of-Care Diagnostics in Obstetric Emergencies
  • Point-of-Care Ultrasound (POCUS / FAST)

Bedside ultrasound performed in the obstetric emergency unit provides immediate diagnostic confirmation:

Obstetric FAST Examination (Focused Assessment with Sonography for Trauma / Obstetrics): Evaluates the right upper quadrant (Morison's pouch / hepatorenal space), left upper quadrant (splenorenal recess), and pouch of Douglas / pelvis for free anechoic peritoneal fluid indicative of hemoperitoneum from uterine rupture, ruptured cornual ectopic, or intra-abdominal bleeding.

Inferior Vena Cava (IVC) Assessment: A flat, completely collapsing IVC with inspiration (collapsibility index >50% and diameter <1.5 cm) indicates severe intravascular hypovolemia. A plethoric, non-collapsing IVC (>2.1 cm with <50% collapsibility) indicates volume overload or right heart strain.

Bedside Fetal & Placental Ultrasound: Confirms fetal cardiac activity, presentation, placental localization (excluding previa), and biophysical parameters.

Viscoelastic Coagulation Testing: TEG & ROTEM

Standard laboratory coagulation tests (PT/INR, aPTT, Clauss fibrinogen) require 45 to 60 minutes to process—too slow during fulminant obstetric hemorrhage or amniotic fluid embolism. Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM) assess whole-blood viscoelastic properties from clot initiation through fibrinolysis within 10 to 15 minutes at the point of care:

Viscoelastic Parameter (TEG / ROTEM) Physiological Stage Evaluated Normal Range Abnormal Value & Clinical Interpretation Targeted Hemotherapy Action

R-Time (TEG) / CT (ROTEM) Clotting factor initiation time (thrombin generation) R: 4–8 min; CT: 100–240 sec Prolonged R / CT indicates severe clotting factor deficiency or heparin effect. Transfuse Fresh Frozen Plasma (FFP) or 4-Factor Prothrombin Complex Concentrate (PCC).

K-Time / CFT (ROTEM) Clot kinetics and amplification K: 1–3 min; CFT: 70–150 sec Prolonged K / CFT indicates delayed fibrin cross-linking. Administer Cryoprecipitate or Fibrinogen concentrate.

Alpha Angle (Angle / CFT) Rate of fibrin polymerization Angle: 55°–78° Decreased Alpha Angle (<55°) reflects severe hypofibrinogenemia. Transfuse Cryoprecipitate (10–20 units) or Fibrinogen concentrate (target fibrinogen >200 mg/dL).

Maximum Amplitude (MA) / MCF Maximum clot strength (80% platelet function, 20% fibrinogen) MA: 51–69 mm; MCF: 50–72 mm Low MA / MCF (<50 mm) indicates severe thrombocytopenia or platelet dysfunction. Transfuse Platelets (1 apheresis unit) +/- Cryoprecipitate.

LY30 (TEG) / ML (ROTEM) Clot lysis at 30 minutes (fibrinolysis) LY30: 0%–3%; ML: <15% Elevated LY30 (>3%) / ML (>15%) confirms acute hyperfibrinolysis (seen in AFE, massive PPH, severe abruption). Administer Tranexamic Acid (TXA) 1 g IV over 10 minutes.

Point-of-Care Blood Gas & Lactate

Serum Lactate: Normal pregnancy lactate is <1.5 to 2.0 mmol/L. A point-of-care lactate >2.0 mmol/L signals cellular tissue hypoperfusion; lactate >=4.0 mmol/L indicates severe anaerobic metabolism, lactic acidosis, and impending metabolic collapse.

Base Excess / Deficit: Base deficit worse than -6 to -8 mEq/L correlates strongly with significant uncompensated blood loss and systemic acidemia.

Loading diagram... Maternal Early Warning Trigger (MEWT) & Shock Cascade